Home › NDC Lookup › Ingredients › Atorvastatin Calcium › 68084-0098-01
⚪image loading
(from DailyMed)

Atorvastatin Calcium 20 mg Tablet, Film Coated — NDC 68084-098-01 (Billing 68084-0098-01)

by American Health Packaging · 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, FILM COATED in 1 BLISTER PACK

This is a package of Atorvastatin Calcium 20 mg Tablet, Film Coated from American Health Packaging, marketed since Jul 2013 and currently FDA-listed; retail pharmacies pay about $0.0279 per unit (NADAC). It is this product's only package size.

NDC 68084-0098-01
🏷️ FDA NDC (as labeled) 68084-098-01 billing pads the product segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 68084-098-01 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
68084 labeler · 098 product · 01 package
Package marketed since
Jul 9, 2013
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 6808409801 7
Medicaid fills, this package
396 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026
⚠️
Other active recalls for Atorvastatin Calcium (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0020-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0019-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0017-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0018-2026
Class II · Mar 17, 2025 — Failed dissolution specifications: lower than specifications (BIOCON PHARMA INC) · FDA recall D-0306-2025
Class II · Mar 16, 2023 — CGMP Deviations (Northwind Pharmaceuticals LLC) · FDA recall D-0548-2023
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68084-098-01
Product NDC 68084-098
11-digit billing NDC 68084009801
NCPDP billing unit EA — each (per item)
Application # ANDA090548
SPL Set ID 5b270c30-60ac-ce78-e063-6294a90ab2d5
Established class (EPC) HMG-CoA Reductase Inhibitor
Mechanism of action Hydroxymethylglutaryl-CoA Reductase Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-07-09
Route ORAL
Dosage form TABLET, FILM COATED
Substance ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 029968
GCN 43721
HICL code 012404
Ingredient (HICL) Atorvastatin Calcium
HIC1 code M
Therapeutic class — broad (HIC1) Blood
HIC2 code M4
Therapeutic class — intermediate (HIC2) Affect Blood Lipids/Sugar/Amino Acids
HIC3 code M4D
Therapeutic class — specific (HIC3) Antihyperlipidemic-Hmgcoa Reductase Inhib(Statins)
AHFS code 24:06.08.00
AHFS class Hmg-Coa Reductase Inhibitors
FDB label name ATORVASTATIN 20 MG TABLET
FDB brand name Atorvastatin Calcium
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 029968
  • GCN: 43721
  • HICL (First Databank): 012404
  • AHFS class code: 24:06.08.00
Why two NDCs? The FDA registers this code as 68084-098-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68084-0098-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name ATORVASTATIN 20 MG TABLET Ingredient Atorvastatin Calcium
📖 What it is MedlinePlus · NLM

Atorvastatin is used to reduce the risk of heart attack and stroke decrease the amount of cholesterol (a fat-like substance that can build up and clog blood vessels causing heart attacks or strokes or other health problems) Atorvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing how much cholesterol your body makes. This lowers the amount of cholesterol that can build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It lowers LDL cholesterol and triglycerides when used with diet. It also lowers the risk of heart attack and stroke in adults who have CHD or are at higher risk, including people w...
  • Take it by mouth once a day. Any time of day works, and you can take it with or without food. Pick a time you will remember. If you miss a dose, one label says to skip it and take...
  • Common ones include stuffy nose, joint or muscle aches, diarrhea, upset stomach, and trouble sleeping. Many people have few problems. If muscle pain is unexplained or comes with we...
  • Call for unexplained muscle pain, tenderness or weakness, especially with fever. Also call for yellow skin or eyes, or signs of a serious allergy like facial swelling or a blisteri...
📖 Read our full Atorvastatin guide →
2
Nutrient depletion considerations

Atorvastatin Calcium may be associated with lower levels of 2 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Atorvastatin Calcium nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.028 $2.79 / 100 tablet
Medicaid paysCMS SDUD · 12 mo $0.4554 $45.54 / 100 tablet
Medicare drug plans payPart D · Q2 2026 $0.0927 $9.27 / 100 tablet
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.055 $0.028
▼ Down 40% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68084-0098-01 You're viewing this Main listing 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, FILM COATED in 1 BLISTER PACK 2013-06-18 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Atorvastatin Calcium 20 mg 00093-5059-10 Teva 1000 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 00378-3951-05 Mylan 500 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 00480-3586-10 Teva 1000 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 00904-6291-06 Major 1 tablet $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 16571-0137-09 Rising 90 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 31722-0425-05 Camber 500 tablets $0.028 AB Availability likely —
Atorvastatin calcium 20 mg 33342-0316-10 Macleods 90 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 42385-0941-01 Laurus 100 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 42571-0173-10 Micro 1000 tablets $0.028 — Discontinued —
Atorvastatin Calcium 20 mg 43598-0099-05 Dr. 500 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 43598-0831-05 Dr. 500 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 50228-0452-05 ScieGen 500 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 50268-0094-15 AvPAK 1 tablet $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 51079-0209-20 Mylan 1 tablet $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 55111-0122-05 Dr. 500 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 67877-0512-05 Ascend 500 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mgthis 68084-0098-01 American 1 tablet $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 70377-0078-11 Biocon 90 tablets $0.028 AB Availability likely —
atorvastatin calcium 20 mg 70710-1775-00 Zydus 1000 tablets $0.028 AB Availability likely —
Atorvastatin calcium 20 mg 70756-0248-12 Lifestar 1000 tablets $0.028 AB Availability likely —
Atorvastatin calcium 20 mg 72205-0023-05 Novadoz 500 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 72603-0283-01 NorthStar 90 tablets $0.028 AB Availability likely —
Atorvastatin calcium 20 mg 72603-0404-02 NorthStar 100 tablets $0.028 AB Availability likely —
Atorvastatin calcium 20 mg 75834-0256-01 NIVAGEN 1000 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 82009-0002-10 Quallent 1000 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 82009-0177-10 Quallent 1000 tablets $0.028 AB Availability likely —
Atorvastatin Calcium 20 mg 16714-0174-01 NORTHSTAR 90 tablets $0.029 AB Discontinued +2%
Atorvastatin Calcium 20 mg 16729-0045-15 Accord 90 tablets $0.041 AB FDA listed +47%
Atorvastatin Calcium 20 mg 69097-0945-05 Cipla 90 tablets $0.041 AB FDA listed +47%
Lipitor 20 mg 58151-0156-77 Viatris 90 tablets $19.073 AB Availability likely +68212%
Atorvastatin Calcium 20 mg 00615-8007-05 NCS 15 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 42708-0004-30 QPharma, 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 42708-0013-30 QPharma, 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 42708-0141-30 QPharma, 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 43063-0496-30 PD-Rx 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 48433-0008-20 Safecor 1 tablet — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-5181-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-5182-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-5634-00 A-S 30 tablets — — FDA listed —
Atorvastatin Calcium 20 mg 50090-6481-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-6482-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-7386-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-7387-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-7528-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 50090-7529-00 A-S 90 tablets — AB FDA listed —
atorvastatin calcium 20 mg 50090-7722-00 A-S 30 tablets — AB FDA listed —
atorvastatin calcium 20 mg 50090-7723-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 51655-0464-52 Northwind 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 51655-0920-26 Northwind 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 55154-6634-00 Cardinal 1 tablet — AB FDA listed —
Atorvastatin Calcium 20 mg 55154-7630-00 Cardinal 1 tablet — AB FDA listed —
Atorvastatin Calcium 20 mg 59651-0607-60 Aurobindo 60000 tablets — AB FDA listed —
Atorvastatin calcium 20 mg 60290-0040-01 Umedica 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 60505-2579-00 Apotex 10 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 60760-0883-90 St. 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 63187-0108-30 Proficient 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 63629-8470-01 Bryant 500 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 63629-8471-01 Bryant 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 67046-1403-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 67046-1453-03 Coupler 30 tablets — — FDA listed —
Atorvastatin calcium 20 mg 67046-1505-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 67046-1526-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 67046-1643-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68071-2824-09 NuCare 90 tablets — — FDA listed —
Atorvastatin calcium 20 mg 68071-2967-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68071-3580-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68071-3659-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68071-3714-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68071-3891-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68071-4840-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68071-5168-03 NuCare 30 tablets — AB FDA listed —
Atorvastatin calcium 20 mg 68071-5292-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin calcium 20 mg 68788-4096-03 Preferred 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68788-8625-01 Preferred 100 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68788-8683-01 Preferred 100 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 68788-8693-01 Preferred 100 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 69097-0898-05 Cipla 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 70518-0186-00 REMEDYREPACK 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 70518-3037-00 REMEDYREPACK 30 tablets — AB Discontinued —
Atorvastatin calcium 20 mg 70518-3339-00 REMEDYREPACK 30 tablets — AB Discontinued —
Atorvastatin calcium 20 mg 70518-3783-00 REMEDYREPACK 30 tablets — AB Discontinued —
Atorvastatin calcium 20 mg 70518-4423-00 REMEDYREPACK 100 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 70518-4587-00 REMEDYREPACK 30 tablets — AB FDA listed —
atorvastatin calcium 20 mg 70771-1876-00 Zydus 1000 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 71205-0247-30 Proficient 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 71209-0091-04 Cadila 90 tablets — — FDA listed —
Atorvastatin Calcium 20 mg 71335-1010-01 Bryant 30 tablets — — FDA listed —
Atorvastatin Calcium 20 mg 71335-1051-01 Bryant 30 tablets — AB Discontinued —
Atorvastatin Calcium 20 mg 71335-1507-01 Bryant 30 tablets — AB Discontinued —
Atorvastatin Calcium 20 mg 71335-1929-01 Bryant 30 tablets — — FDA listed —
Atorvastatin calcium 20 mg 71335-2213-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 71335-2393-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 71335-2404-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin calcium 20 mg 71335-2799-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 71610-0022-45 Aphena 45 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 71610-0744-15 Aphena 15 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 72162-1555-05 Bryant 500 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 72162-1712-02 Bryant 9 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 72189-0291-90 DirectRX 90 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 72189-0587-30 Direct_Rx 30 tablets — AB FDA listed —
Atorvastatin calcium 20 mg 72789-0084-30 PD-Rx 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 76420-0945-00 Asclemed 1000 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 77771-0452-05 Radha 500 tablets — AB FDA listed —
atorvastatin calcium 20 mg 82137-0017-01 Lepu 90 tablets — — FDA listed —
Atorvastatin Calcium 20 mg 82804-0054-30 Proficient 30 tablets — AB FDA listed —
Atorvastatin Calcium 20 mg 82804-0161-30 Proficient 30 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2013
On the market since
Jul 2013
📍
2026
Currently FDA-listed
13 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Atorvastatin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerican Health Packaging
Application holderAPOTEX INC
FDA applicationANDA090548 (ANDA)
Labeler code68084
First marketedJul 2013
Product typeHuman Prescription Drug
Portfolio674 products on file

More NDCs from American Health Packaging labeler code 68084

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
396
Units reimbursed last 4 qtrs
9K
Gross reimbursed last 4 qtrs
$4.1K
Avg / prescription
$10.37
Avg / unit
$0.4554
Latest quarter Q1 2026
129Rx
Medicaid pays / ea
$0.4554
gross reimbursed
vs
NADAC / ea
$0.0279
acquisition cost
=
Spread
+$0.4275
+1532% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
85% FFS 15% MCO
Fee-for-service · 338 Rx Managed care · 58 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 8,868 units · 22.8 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 45 units · 1.0 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: 106 units · 2.3 per 100k residents LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
1.022.8
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 22.8 /100k
2 Louisiana 2.3 /100k
3 Kentucky 1.0 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Atorvastatin Calcium — the program that covers self-administered drugs. 26 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Atorvastatin Calcium. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$194.53M
Claims incl. refills
18.7M
Beneficiaries
14.7M
Spend / beneficiary
$13.26
Spend / claim
$10.38
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 68084-0097-01 · American 68084-0099-01 · American →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.